S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
18.51
+1.83
+10.97%
CRL · Charles River Laboratories International, Inc.
NEW YORK STOCK EXCHANGE, INC. - Real Time Price • USD
Charles River Laboratories International Inc (CRL)
NEW YORK STOCK EXCHANGE, INC.
Life Sciences Tools & Services
$344.83
+29.38
(+9.31%)
● At close: October 21 at 4:00:00 PM EDT
$344.49
-0.32
(-0.09%)
Pre-Market:
4:00:05 AM EDT
DAY'S RANGE
$344.83
$319.62
$348.60
52-WEEK RANGE
$344.83
$146.20
$333.30
What's happening
- CRL is up 9.31% today, trading at $344.83. — Live quote
- It's trading within 3% of its 52-week high ($333.30). (Finnhub fundamentals)
- Volume today (178,985) is well below its 3-month average of 929,820. (Finnhub fundamentals)
- Reports earnings on 2026-11-04 (before market open), 13 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $3.02 actual vs. $2.76 estimated (+9.2%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 7
Buy 11
Hold 5
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (23 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
CRL
+58.14%
vs S&P 500
+45.36%
1-YEAR RETURN
CRL
+71.31%
vs S&P 500
+56.75%
6-MONTH RETURN
CRL
+78.28%
3-MONTH RETURN
CRL
+43.78%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$3.02
Est. $2.76
BEAT +9.2%
2026-04-26 (Q1 2026)
$2.06
Est. $1.96
BEAT +5.0%
2026-01-26 (Q4 2025)
$2.39
Est. $2.37
BEAT +1.0%
2025-10-26 (Q3 2025)
$2.43
Est. $2.36
BEAT +2.9%
Valuation Measures & Ratios
Enterprise Value4$18.52B
Forward P/E530.31
PEG Ratio6-0.24
Price / Sales (TTM1)4.02
Price / Book73.83
EV4 / Revenue4.63
EV4 / EBITDA109.92
Profit Margin-5.96%
Operating Margin2.25%
Return on Equity (ROE8)-7.72%
Return on Assets (ROA9)-3.19%
Avg Volume (3M)929,820
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $10.65B | $7.88B | $7.36B | $7.41B | $7.92B |
| P/E | 117.83 | 67.12 | 36.44 | 30.66 | 30.22 |
| Price/Sales | 2.64 | 1.96 | 1.82 | 1.83 | 1.97 |
| Price/Book | 3.75 | 2.68 | 2.16 | 2.21 | 2.48 |
| EV/Revenue | 2.59 | 1.92 | 1.77 | 1.78 | 1.91 |
| EV/EBITDA | 12.88 | 9.37 | 8.52 | — | — |
| ROE | 3.18% | 3.99% | 5.93% | 7.20% | 8.21% |
| ROA | 1.20% | 1.52% | 2.69% | 3.19% | 3.46% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short2,878,537
Change from Prior Settlement+29.05%
% of Float—
Days to Cover (Short Ratio)2.69
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Trailing 52-week price return is +71.3%. Finnhub market metrics ↗
- Latest SEC filing is Form 4, filed 2026-10-07; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Revenue growth is -2.7% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is -6.0%. Finnhub fundamentals ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on CRL
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.00B | $995.8M | $1.00B | $1.03B | $984.2M | $1.01B | $1.03B | $1.01B |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $119.9M | $119.9M | $133.8M | $100.1M | $74.7M | $117.4M | $151.7M | $126.0M |
| Net income | -$1.5M | -$14.8M | $54.4M | $52.3M | $25.5M | $69.7M | $94.1M | $73.0M |
| EPS (diluted) | $-0.03 | $-0.30 | $1.10 | $1.06 | $0.50 | $1.33 | $1.74 | $1.30 |
| EPS (basic) | $-0.03 | $-0.30 | $1.11 | $1.06 | $0.50 | $1.34 | $1.75 | $1.31 |
| Operating margin | $12 | $12 | $13 | $10 | $8 | $12 | $15 | $12 |
| Net margin | -$0 | -$1 | $5 | $5 | $3 | $7 | $9 | $7 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $7.53B | $7.73B | $7.14B | $7.51B | $7.56B | $7.58B | $7.53B | $8.00B |
| Total liabilities | $4.64B | $4.74B | $3.92B | $4.06B | $4.16B | $4.34B | $4.02B | $4.18B |
| Stockholders' equity | $2.84B | $2.94B | $3.16B | $3.41B | $3.35B | $3.19B | $3.46B | $3.78B |
| Total current assets | $1.53B | $1.49B | $1.45B | $1.53B | $1.47B | $1.51B | $1.40B | $1.49B |
| Total current liabilities | $1.13B | $1.09B | $1.12B | $1.12B | $1.08B | $1.05B | $994.1M | $1.01B |
| Cash & equivalents | $192.0M | $191.8M | $213.8M | $207.1M | $182.8M | $229.4M | $194.6M | $210.2M |
| Marketable securities (current) | — | — | — | — | — | — | — | — |
| Accounts receivable | $711.8M | $700.3M | $708.9M | $734.5M | $767.6M | $756.6M | $720.9M | $754.2M |
| Inventory | $346.3M | $359.7M | $299.1M | $302.6M | $279.6M | $290.2M | $278.5M | $336.2M |
| Other current assets | — | — | — | — | — | — | — | — |
| Marketable securities (non-current) | — | — | — | — | — | — | — | — |
| Property, plant & equipment | $1.49B | $1.51B | $1.66B | $1.59B | $1.61B | $1.59B | $1.60B | — |
| Goodwill | $3.08B | $3.04B | $2.76B | $2.92B | $2.94B | $2.87B | $2.85B | $3.12B |
| Intangible assets | $253.2M | $249.0M | $340.0M | $571.1M | $602.5M | $655.7M | $723.4M | $778.5M |
| Other non-current assets | $587.6M | $826.2M | $293.2M | $290.9M | $296.5M | $294.1M | $278.2M | $307.0M |
| Accounts payable | $141.0M | $134.0M | $148.8M | $169.6M | $145.8M | $149.3M | $140.3M | $136.0M |
| Accrued liabilities | $380.1M | $372.4M | $270.1M | $228.9M | $231.6M | $242.5M | $232.0M | $208.1M |
| Deferred revenue (current) | $203.0M | $194.3M | $210.4M | $237.7M | $268.3M | $250.5M | $248.3M | $252.0M |
| Short-term debt | $5.5M | $6.7M | $166.0K | $54.0K | $98.0K | $121.0K | $155.0K | $157.0K |
| Other current liabilities | $222.8M | $226.1M | $222.2M | $216.0M | $207.2M | $211.5M | $194.0M | $205.1M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Other non-current liabilities | $402.5M | $510.6M | $138.3M | $189.5M | $185.2M | $196.4M | $195.2M | $236.7M |
| Common stock & paid-in capital | $496.0K | $493.0K | $492.0K | $514.0K | $513.0K | $512.0K | $511.0K | $517.0K |
| Retained earnings | $1.37B | $1.37B | $1.39B | $1.94B | $1.89B | $1.84B | $1.81B | $2.12B |
| Accumulated other comprehensive income (loss) | -$196.0M | -$191.0M | -$171.8M | -$191.6M | -$166.5M | -$265.2M | -$317.3M | -$192.9M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $179.7M | $41.1M | $147.5M | $213.8M | $204.6M | $171.7M | $159.4M | $251.8M |
| Investing cash flow | $28.1M | -$407.8M | -$92.8M | -$33.7M | -$37.3M | -$45.5M | -$76.1M | -$21.3M |
| Financing cash flow | -$164.7M | $347.7M | -$51.9M | -$152.6M | -$226.9M | -$105.3M | -$75.9M | -$207.5M |
| Depreciation & amortization | $67.3M | $67.2M | $282.9M | $85.2M | $119.5M | $120.4M | $276.4M | $88.2M |
| Share-based compensation | $19.8M | $22.4M | $17.6M | $23.3M | $17.0M | $13.1M | $17.2M | $19.3M |
| Deferred income taxes | — | — | -$75.4M | — | — | — | -$67.2M | — |
| Change in accounts receivable | $21.8M | $65.3M | -$27.6M | -$26.6M | -$10.9M | $29.4M | -$3.3M | -$17.2M |
| Change in inventory | -$17.7M | -$26.0M | $3.5M | $31.3M | -$7.9M | $21.9M | -$3.0M | -$4.0M |
| Change in accounts payable | $821.0K | $20.5M | -$37.9M | $24.5M | -$9.0M | $25.3M | -$7.2M | -$659.0K |
| Purchases of investments | $3.3M | $8.5M | $7.5M | $4.5M | $2.8M | $5.3M | $7.6M | $9.7M |
| Sales/maturities of investments | — | — | — | — | — | — | — | — |
| Other investing activities | -$159.0K | $1.5M | -$210.0K | -$2.8M | -$243.0K | -$104.0K | -$4.9M | -$12.0K |
| Share repurchases | $115.6M | $208.3M | $96.0K | $93.0K | $7.4M | $353.1M | $124.0K | $100.8M |
| Debt issued | $352.8M | $912.5M | $156.7M | $107.5M | $547.0M | $416.3M | $104.8M | $235.6M |
| Other financing activities | -$607.0K | -$2.0M | -$1.3M | -$6.2M | -$6.5M | $0 | -$4.5M | -$13.5M |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $4.02B | $4.05B | $4.13B | $3.98B | $3.54B |
| Operating income | $25.2M | $227.3M | $617.3M | $651.0M | $589.9M |
| Net income | -$144.3M | $22.2M | $474.6M | $486.2M | $391.0M |
| EPS (diluted) | $-2.91 | $0.20 | $9.22 | $9.48 | $7.60 |
| EPS (basic) | $-2.91 | $0.20 | $9.27 | $9.57 | $7.77 |
| Operating margin | $1 | $6 | $15 | $16 | $17 |
| Net margin | -$4 | $1 | $11 | $12 | $11 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $7.14B | $7.53B | $8.20B | $7.60B | $7.02B |
| Total liabilities | $3.92B | $4.02B | $4.54B | $4.58B | $4.43B |
| Stockholders' equity | $3.16B | $3.46B | $3.60B | $2.98B | $2.53B |
| Total current assets | $1.45B | $1.40B | $1.61B | $1.44B | $1.27B |
| Total current liabilities | $1.12B | $994.1M | $1.06B | $1.09B | $1.03B |
| Cash & equivalents | $213.8M | $194.6M | $276.8M | $233.9M | $241.2M |
| Marketable securities (current) | — | — | — | — | $1.1M |
| Accounts receivable | $708.9M | $720.9M | $780.4M | $752.4M | $642.9M |
| Inventory | $299.1M | $278.5M | $380.3M | $255.8M | $199.1M |
| Other current assets | — | — | — | — | — |
| Marketable securities (non-current) | — | — | — | — | — |
| Property, plant & equipment | $1.66B | $1.60B | $1.64B | $1.47B | $1.29B |
| Goodwill | $2.76B | $2.85B | $3.10B | $2.85B | $2.71B |
| Intangible assets | $340.0M | $723.4M | $864.1M | $955.3M | $1.06B |
| Other non-current assets | $293.2M | $278.2M | $309.4M | $148.3M | $151.5M |
| Accounts payable | $148.8M | $140.3M | $168.9M | $205.9M | $198.1M |
| Accrued liabilities | $270.1M | $232.0M | $227.8M | $219.8M | $228.8M |
| Deferred revenue (current) | $210.4M | $248.3M | $241.8M | $264.3M | $219.7M |
| Short-term debt | $166.0K | $155.0K | $3.2M | $1.3M | $101.0K |
| Other current liabilities | $222.2M | $194.0M | $203.2M | $204.6M | $140.4M |
| Long-term debt | — | — | — | — | — |
| Other non-current liabilities | $138.3M | $195.2M | $223.2M | $174.8M | $242.9M |
| Common stock & paid-in capital | $492.0K | $511.0K | $513.0K | $509.0K | $505.0K |
| Retained earnings | $1.39B | $1.81B | $1.89B | $1.43B | $980.8M |
| Accumulated other comprehensive income (loss) | -$171.8M | -$317.3M | -$196.4M | -$262.1M | -$164.7M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | $737.6M | $734.6M | $683.9M | $619.6M | $760.8M |
| Investing cash flow | -$209.3M | -$245.1M | -$563.2M | -$607.9M | -$1.44B |
| Financing cash flow | -$536.7M | -$550.9M | -$85.5M | -$42.4M | $672.6M |
| Depreciation & amortization | $403.3M | $361.7M | $314.1M | $303.9M | $265.5M |
| Share-based compensation | $71.1M | $69.9M | $72.0M | $73.6M | $71.5M |
| Deferred income taxes | -$75.4M | -$67.2M | -$51.3M | -$33.1M | -$20.3M |
| Change in accounts receivable | -$35.7M | -$21.6M | $33.4M | $150.6M | $26.6M |
| Change in inventory | $48.8M | -$16.8M | $62.3M | $78.5M | $25.2M |
| Change in accounts payable | $2.9M | -$14.3M | -$20.4M | -$2.7M | $44.9M |
| Purchases of investments | $20.1M | $52.9M | $54.2M | $158.3M | $45.6M |
| Sales/maturities of investments | — | — | — | — | — |
| Other investing activities | -$3.4M | -$4.5M | $2.3M | $9.3M | -$264.0K |
| Share repurchases | $360.7M | $119.2M | $24.2M | $38.7M | $40.7M |
| Debt issued | $1.23B | $1.08B | $776.4M | $2.95B | $6.95B |
| Other financing activities | -$14.0M | -$31.4M | -$4.1M | -$7.8M | $0 |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding CRL as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-05-29 to 2026-10-05
Recent transactions
- Insiders have net sold 166,961 shares over the last 182 days, across 1 purchase and 19 sales.
- Most recent: Parisotto Shannon M (CEVP, Disc & Safety Assessment) — Option exercise of 981 shares on 2026-10-05.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)10 sh(1 txns)
Sales (open market)166,971 sh(19 txns)
Net Shares-166,961
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Parisotto Shannon M | CEVP, Disc & Safety Assessment | Option exercise | 2026-10-05 | 981 |
| Coleman Glenn | EVP & Chief Financial Officer | Open market purchase | 2026-09-30 | 10 |
| FOSTER JAMES C | Director | Option exercise | 2026-08-25 | 21,132 |
| Girshick Birgit | Chief Executive Officer | Gift | 2026-08-19 | 528 |
| Andrews Nancy C | Director | Option exercise | 2026-08-18 | 573 |
| LaPlume Joseph W | EVP, Corp Strategy & Develop | Gift | 2026-08-10 | 257 |
| Knell Michael Gunnar | SVP, Finance and CAO | Open market sale | 2026-08-06 | 1,274 |
| Creamer Victoria L | EVP & Chief People Officer | Option exercise | 2026-08-06 | 4,179 |
| Barg Steven | Director | Grant / award | 2026-06-02 | 422 |
| Mintz Mark | EVP, Chief Information Officer | Tax withholding | 2026-05-31 | 64 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-05 | Parisotto Shannon M | CEVP, Disc & Safety Assessment | Option exercise | 981 | $208.44 |
| 2026-10-05 | Parisotto Shannon M | CEVP, Disc & Safety Assessment | Open market sale | 981 | $308.44 |
| 2026-09-30 | Coleman Glenn | EVP & Chief Financial Officer | Open market purchase | 10 | $297.43 |
| 2026-08-25 | FOSTER JAMES C | Director | Option exercise | 21,132 | $194.12 |
| 2026-08-25 | FOSTER JAMES C | Director | Option exercise | 12,429 | $208.44 |
| 2026-08-25 | FOSTER JAMES C | Director | Open market sale | 33,561 | $300.00 |
| 2026-08-19 | Girshick Birgit | Chief Executive Officer | Gift | 528 | $0.00 |
| 2026-08-19 | Parisotto Shannon M | CEVP, Disc & Safety Assessment | Option exercise | 2,039 | $194.12 |
| 2026-08-19 | Parisotto Shannon M | CEVP, Disc & Safety Assessment | Open market sale | 2,039 | $294.12 |
| 2026-08-18 | Andrews Nancy C | Director | Option exercise | 573 | $164.30 |
| 2026-08-18 | Andrews Nancy C | Director | Open market sale | 573 | $285.24 |
| 2026-08-11 | Girshick Birgit | Chief Executive Officer | Option exercise | 6,500 | $179.66 |
| 2026-08-11 | Girshick Birgit | Chief Executive Officer | Open market sale | 6,500 | $279.90 |
| 2026-08-11 | Parisotto Shannon M | CEVP, Disc & Safety Assessment | Option exercise | 3,714 | $179.66 |
| 2026-08-11 | Parisotto Shannon M | CEVP, Disc & Safety Assessment | Open market sale | 3,714 | $279.66 |
| 2026-08-10 | LaPlume Joseph W | EVP, Corp Strategy & Develop | Gift | 257 | $0.00 |
| 2026-08-10 | FOSTER JAMES C | Director | Option exercise | 28,733 | $179.66 |
| 2026-08-10 | FOSTER JAMES C | Director | Open market sale | 28,733 | $275.00 |
| 2026-08-06 | Knell Michael Gunnar | SVP, Finance and CAO | Open market sale | 1,274 | $259.07 |
| 2026-08-06 | Knell Michael Gunnar | SVP, Finance and CAO | Open market sale | 901 | $260.63 |
| 2026-08-06 | Knell Michael Gunnar | SVP, Finance and CAO | Open market sale | 810 | $261.45 |
| 2026-08-06 | Knell Michael Gunnar | SVP, Finance and CAO | Open market sale | 213 | $262.37 |
| 2026-08-06 | Knell Michael Gunnar | SVP, Finance and CAO | Open market sale | 620 | $263.94 |
| 2026-08-06 | Knell Michael Gunnar | SVP, Finance and CAO | Open market sale | 482 | $265.17 |
| 2026-08-06 | Knell Michael Gunnar | SVP, Finance and CAO | Option exercise | 404 | $179.66 |
| 2026-08-06 | Knell Michael Gunnar | SVP, Finance and CAO | Option exercise | 1,205 | $194.12 |
| 2026-08-06 | Knell Michael Gunnar | SVP, Finance and CAO | Option exercise | 736 | $208.44 |
| 2026-08-06 | Knell Michael Gunnar | SVP, Finance and CAO | Open market sale | 404 | $258.53 |
| 2026-08-06 | Knell Michael Gunnar | SVP, Finance and CAO | Open market sale | 1,205 | $258.53 |
| 2026-08-06 | Knell Michael Gunnar | SVP, Finance and CAO | Open market sale | 736 | $258.53 |
| 2026-08-06 | Creamer Victoria L | EVP & Chief People Officer | Option exercise | 4,179 | $179.66 |
| 2026-08-06 | Creamer Victoria L | EVP & Chief People Officer | Open market sale | 4,179 | $259.16 |
| 2026-08-05 | Parisotto Shannon M | CEVP, Disc & Safety Assessment | Open market sale | 5,046 | $263.00 |
| 2026-06-29 | FOSTER JAMES C | Director | Open market sale | 75,000 | $225.00 |
| 2026-06-05 | FOSTER JAMES C | Director | Gift | 153,361 | $0.00 |
| 2026-06-05 | FOSTER JAMES C | Director | Gift | 153,361 | $0.00 |
| 2026-06-05 | FOSTER JAMES C | Director | Gift | 20,000 | $0.00 |
| 2026-06-05 | FOSTER JAMES C | Director | Gift | 20,000 | $0.00 |
| 2026-06-05 | FOSTER JAMES C | Director | Gift | 10,000 | $0.00 |
| 2026-06-05 | FOSTER JAMES C | Director | Gift | 10,000 | $0.00 |
| 2026-06-05 | Girshick Birgit | Chief Executive Officer | Gift | 3,386 | $0.00 |
| 2026-06-05 | Girshick Birgit | Chief Executive Officer | Gift | 3,386 | $0.00 |
| 2026-06-05 | Parisotto Shannon M | CEVP, Disc & Safety Assessment | Gift | 1,529 | $0.00 |
| 2026-06-05 | Parisotto Shannon M | CEVP, Disc & Safety Assessment | Gift | 1,529 | $0.00 |
| 2026-06-02 | Barg Steven | Director | Grant / award | 422 | $174.79 |
| 2026-05-31 | Mintz Mark | EVP, Chief Information Officer | Tax withholding | 64 | $180.71 |
| 2026-05-31 | LaPlume Joseph W | EVP, Corp Strategy & Develop | Tax withholding | 235 | $180.71 |
| 2026-05-31 | Knell Michael Gunnar | SVP, Finance and CAO | Tax withholding | 48 | $180.71 |
| 2026-05-31 | Girshick Birgit | Chief Executive Officer | Tax withholding | 378 | $180.71 |
| 2026-05-31 | Creamer Victoria L | EVP & Chief People Officer | Tax withholding | 194 | $180.71 |
| 2026-05-30 | Mintz Mark | EVP, Chief Information Officer | Tax withholding | 305 | $180.71 |
| 2026-05-30 | LaPlume Joseph W | EVP, Corp Strategy & Develop | Tax withholding | 744 | $180.71 |
| 2026-05-30 | Knell Michael Gunnar | SVP, Finance and CAO | Tax withholding | 152 | $180.71 |
| 2026-05-30 | Girshick Birgit | Chief Executive Officer | Tax withholding | 1,204 | $180.71 |
| 2026-05-30 | FOSTER JAMES C | Director | Tax withholding | 1,596 | $180.71 |
| 2026-05-30 | Creamer Victoria L | EVP & Chief People Officer | Tax withholding | 616 | $180.71 |
| 2026-05-29 | Coleman Glenn | EVP & Chief Financial Officer | Grant / award | 6,640 | $180.71 |
| 2026-05-29 | Mintz Mark | EVP, Chief Information Officer | Grant / award | 2,534 | $180.71 |
| 2026-05-29 | LaPlume Joseph W | EVP, Corp Strategy & Develop | Grant / award | 5,257 | $180.71 |
| 2026-05-29 | Knell Michael Gunnar | SVP, Finance and CAO | Grant / award | 1,837 | $180.71 |
Showing the most recent 60 transactions.
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 07:48 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-07 | 4 | 2026-10-05 | View on SEC.gov → |
| 2026-10-02 | 4 | 2026-09-30 | View on SEC.gov → |
| 2026-09-24 | 8-K | 2026-09-24 | View on SEC.gov → |
| 2026-08-27 | 4 | 2026-08-25 | View on SEC.gov → |
| 2026-08-20 | 4 | 2026-08-19 | View on SEC.gov → |
| 2026-08-20 | 4 | 2026-08-19 | View on SEC.gov → |
| 2026-08-20 | 4 | 2026-08-18 | View on SEC.gov → |
| 2026-08-13 | 4 | 2026-08-11 | View on SEC.gov → |
| 2026-08-13 | 4 | 2026-08-11 | View on SEC.gov → |
| 2026-08-11 | 4 | 2026-08-10 | View on SEC.gov → |
| 2026-08-11 | 4 | 2026-08-10 | View on SEC.gov → |
| 2026-08-10 | 4 | 2026-08-06 | View on SEC.gov → |
Recent news
Headlines about CRL (Charles River Laboratories International, Inc.). Links open the publisher — we don’t host full articles.
-
Charles River (CRL) Stock Charges Higher On Bullish Targets And AI Hype
Timothy Sykes · 2026-10-21 -
Charles River Laboratories International Jumps 7.3% in Broad Rally
AlphaStreet · 2026-10-21 -
S&P 500 Top Movers: Oct. 21, 2026 US Session
ChartMill · 2026-10-21 -
Charles River (CRL) Stock Climbs As Wall Street Turns Bullish
Timothy Sykes · 2026-10-21 -
S&P 500 Top Movers on Oct. 21, 2026: Supermicro Leads Gainers, Dexcom Leads Losers
ChartMill · 2026-10-21 -
CRL Nov 2026 300.000 put (CRL261120P00300000) stock price, news, quote and history
Yahoo Finance UK · 2026-10-21 -
Charles River Laboratories International, Inc. (CRL) stock price, news, quote and history
Yahoo Finance UK · 2026-10-21 -
Charles River Laboratories International, Inc. (CRL) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-21
No headlines in this category right now — try “All”.